Keros Therapeutics, Inc. - COM (KROS)

Q2 2021 13F Holders as of 6/30/2021

Type / Class
Equity / COM
Number of holders
78
Total Shares
14.1M
Shares change
-292K
Total reported value, excl. options
$599M
Value change
-$43.6M
Put/Call ratio
0
Number of buys
51
Number of sells
-33
Price
$42.47
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.